I read the article by Driver et al. (1), which was recently published in the Journal, with great interest. The investigators reported that to assess the initial risk of atherosclerotic cardiovascular disease in an untreated patient, fasting or nonfasting total cholesterol and high-density lipoprotein cholesterol (HDL-C) levels provide all that is required. Among those with a nonfasting non–HDL-C level ≥220 mg/dl, a familial cause of hyperlipidemia should be suspected and evaluated further (1).
http://ift.tt/2cYiTRJ
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου